Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common ...
Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback